By EconMatters
Pershing Square`s Investor Letter provides the backdrop for an analysis or case study on Valeant Pharmaceuticals.
© EconMatters All Rights Reserved | Facebook | Twitter | YouTube | Email Digest | Kindle
via Zero Hedge http://ift.tt/1VNd7lz EconMatters